$2.77
-0.07-2.46%
At Close: -
$2.77
00.00%
After Hours: Sep 20, 4:04 PM EDT
15 minutes delayed
Comments
Loading...
Galectin Therapeutics (GALT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGalectin Therapeutics (NASDAQ:GALT) Stock Quotes, Forecast and News Summary
Galectin Therapeutics Stock (NASDAQ: GALT) stock price, news, charts, stock research, profile.
| Open | $2.85 |
| Close | $2.77 |
| Volume / Avg. | 217.98K / 170.61K |
| Day Range | $2.77 - $2.92 |
| 52 Wk Range | 1.56 - 4.27 |
| Market Cap | $172.51M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 58 |
| Short Interest | 16.88% |
| Days to Cover | 40.2 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Galectin Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Galectin Therapeutics (GALT) stock?
You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.
Who are Galectin Therapeutics (GALT) competitors?
Other companies in Galectin Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Cabaletta Bio (NASDAQ:CABA), Skye Bioscience (NASDAQ:SKYE) and Innate Pharma (NASDAQ:IPHA).
What is the forecast, or price target, for Galectin Therapeutics (GALT) stock?
There is no analysis for Galectin Therapeutics to provide a consensus price target.
What is the current price for Galectin Therapeutics (GALT)?
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.77 last updated September 20, 2024 at 4:04 PM EDT.
Does Galectin Therapeutics (GALT) pay a dividend?
There are no upcoming dividends for Galectin Therapeutics.
When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?
Galectin Therapeutics does not have any upcoming earnings scheduled.
Is Galectin Therapeutics (GALT) going to split?
There is no upcoming split for Galectin Therapeutics.
What sector and industry does Galectin Therapeutics (GALT) operate in?
Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.